Dawidowska, A.; Jagodzinska-Mucha, P.; Koseła-Paterczyk, H.; Jaczewska, S.; Sobczuk, P.; Chelstowska, M.; Kowalska, M.; Badziak-Sterczewska, H.; Poleszczuk, J.; Rutkowski, P.;
et al. Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma. Cancers 2022, 14, 1248.
https://doi.org/10.3390/cancers14051248
AMA Style
Dawidowska A, Jagodzinska-Mucha P, Koseła-Paterczyk H, Jaczewska S, Sobczuk P, Chelstowska M, Kowalska M, Badziak-Sterczewska H, Poleszczuk J, Rutkowski P,
et al. Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma. Cancers. 2022; 14(5):1248.
https://doi.org/10.3390/cancers14051248
Chicago/Turabian Style
Dawidowska, Anna, Paulina Jagodzinska-Mucha, Hanna Koseła-Paterczyk, Sylwia Jaczewska, Paweł Sobczuk, Monika Chelstowska, Maria Kowalska, Honorata Badziak-Sterczewska, Jan Poleszczuk, Piotr Rutkowski,
and et al. 2022. "Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma" Cancers 14, no. 5: 1248.
https://doi.org/10.3390/cancers14051248
APA Style
Dawidowska, A., Jagodzinska-Mucha, P., Koseła-Paterczyk, H., Jaczewska, S., Sobczuk, P., Chelstowska, M., Kowalska, M., Badziak-Sterczewska, H., Poleszczuk, J., Rutkowski, P., & Lugowska, I.
(2022). Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma. Cancers, 14(5), 1248.
https://doi.org/10.3390/cancers14051248
